Zenas BioPharma
Minggeng Gao has a strong background in bioanalytical sciences and drug metabolism and pharmacokinetics. Gao's career has spanned across various pharmaceutical companies, including Zenas BioPharma, GSK, TESARO, Inc., Shire, Alnylam Pharmaceuticals, and Sanofi Genzyme. Gao holds a PhD in Cell/Cellular and Molecular Biology from Ohio University and has completed post-doctoral research at Massachusetts Institute of Technology and Harvard Medical School/Brigham and Women's Hospital. In the current role as Executive Director at Zenas BioPharma, Gao leads the Bioanalytical Sciences department.
This person is not in any offices
Zenas BioPharma
6 followers
Zenas BioPharma is a cross-border (China-USA-based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for patients in China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through its successful business development strategy.